Evidence map›Paper›PMID 37987866›Full record

ArticleWorld journal of urology2023

Positioning the role of urine cytology within the diagnostic pathway for UTUC: supportive but inconclusive.

Orlane J A Figaroa, Nora Hendriks, Guido M Kamphuis, R Jeroen A van Moorselaar, Adriaan D Bins, Joyce Baard

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in World journal of urology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Orlane J A FigaroaDepartment of Urology, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, The Netherlands. o.j.figaroa@amsterdamumc.nl.ORCID http://orcid.org/0000-0002-5284-3515
Nora HendriksDepartment of Urology, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-4605-6283
Guido M KamphuisDepartment of Urology, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-4583-4231
R Jeroen A van MoorselaarDepartment of Urology, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-2559-9254
Adriaan D BinsDepartment of Medical Oncology, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-9794-6526
Joyce BaardDepartment of Urology, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-5509-0213
Amsterdam University Medical Centers · NLCancer Center Amsterdam · NLDutch Cancer Society · NLUniversity of Amsterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeWith the introduction of kidney-sparing surgery (KSS) for low-risk Upper Tract Urothelial Carcinoma (UTUC), correct risk-stratification has become crucial. High-grade cytology is one of the decisive variables to stratify a tumor as high-risk. To position the role of urine cytology in the diagnostic pathway of UTUC patients, we evaluated the accuracy of urine cytology by comparing the outcomes with histopathology.

methodPatients with UTUC evaluated between 2010 and 2020, and diagnosed by imaging, cytology and histopathology were selected. Descriptive statistics were used to compare cytology with histopathological outcomes using crosstabs. Clinical performance characteristics of cytology were determined for the presence of a malignancy.

resultsThis study included 176 patients with confirmed histopathological UTUC. Concordance between cytology and biopsy results was found in 14.8% of low-grade tumors and 16.8% of high-grade tumors. Comparing cytology with radical nephroureterectomy (RNU) specimens revealed concordance rates of 1.6% for low-grade tumors and 22.9% for high-grade tumors. Notably, 51.1% of urine cytology results were false negative. Sensitivity for detecting high-grade and low-grade tumors with a positive urine cytology was 56.6% and 52.6%, respectively, with specificities of 54.8% and 37.2%.

conclusionIn the current study, cytology appears to exhibit limited reliability when used as a sole diagnostic tool for assessing tumor grade and consequently risk stratification. It is imperative to recognize these limitations, optimize urine sampling techniques, and leverage a combination of diverse diagnostic methods for the most effective and individualized treatment decision-making.

Indexed as

Carcinoma, Transitional CellKidney NeoplasmsUreteral NeoplasmsUrinary Bladder NeoplasmsHumansKidneyReproducibility of ResultsCytologyDiagnosticsUpper tract urothelial carcinomaUrothelial carcinoma

Identifiers

PMID37987866
OpenAlexW4388861000

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.